Answers are grounded in this paper and cite their sources.
Allicin exerts its beneficial effects on the metabolic syndrome by considerably reducing systemic and renal inflammation as well as the oxidative stress. These effects were mediated through the Nrf2 pathway. The results suggest allicin may be a therapeutic alternative for treating kidney injury induced by the metabolic syndrome risk factors.
No takes yet. Share an insight, caveat, or question.
Buendía et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: